The nonprofit hospital system stopped suing patients in 2022 and called debt cancellation the “next logical step.”

“Positioned as an extension of traditional examination methods, particularly appealing to the upcoming generation of clinicians, it holds promise in potentially replacing the stethoscope in various medical assessments and procedures.” 

In a statement announcing its lawsuit, the FTC said Caremark, Optum RX and Express Scripts benefit from manufacturer rebates and ignore lower-costing drugs as a way to artificially increase prices. 

The vest offers extended coverage of the breast, axilla and thyroid. It is said to reduce exposure of these areas by nearly 98%. 

"The underrepresentation of women in interventional cardiology is a significant concern," according to one cardiologist behind the new campaign. 

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

Congress is swamped with AI bills. 

The AI advisory board of the United Nations is calling for the creation of a global AI data framework.